Sex, female:male | 8:2 |
Age at LN diagnosis, yrs | 34.2 ± 7.3 |
Disease duration, yrs | 2.2 ± 2.5 |
Race/ethnicity, n | |
Black | 5 |
Hispanic | 2 |
White | 2 |
Asian | 1 |
LN histopathologic class | |
III | 1 |
IV | 5 |
IV/V | 2 |
V | 2 |
Activity index | 5.7 ± 4.9 |
Chronicity index | 3.3 ± 3.0 |
Serum creatinine, μmol/L | 82.1 ± 15.5 |
eGFR, mL/min/1.73 m2 | 90.2 ± 24.9 |
Anemia, n (%)a | 3 (30%) |
Proteinuria, g/24 h | 2.7 ± 1.04 |
Nephrotic syndrome, n (%) | 5 (50%) |
Serum albumin, g/L | 32.5 ± 3.7 |
Hypertension, n (%)b | 5 (50%) |
Time to ESKD, months | 19.2 ± 12.4 |
Rate of renal function decline, mL/min/1.73 m2/yr, median | 43.3 |